Andrew B. Singleton, Ph.D., is the director of a new NIH intramural effort, the Center for Alzheimer’s and Related Dementias (CARD). He received his B.Sc. from the University of Sunderland, U.K. Singleton earned his Ph.D. from the University of Newcastle upon Tyne, U.K. His postdoctoral studies were spent at the Mayo Clinic in Jacksonville Florida. Singleton joined NIH’s NIA IRP in 2001 and became a principal investigator leading it's Molecular Genetics Unit the following year. In 2007, he became an NIA tenured senior investigator and in 2008 he was named chief of the NIA Laboratory of Neurogenetics. His laboratory has worked over the last two decades on the genetic causes and contributors to neurodegenerative diseases and has identified causes and risk factors in Alzheimer’s disease, frontotemporal dementia, Parkinson’s, dementia with Lewy bodies, motor neuron diseases, and rare progressive neurological disorders. In 2016, he became an NIH Distinguished Investigator and, in 2020, Andrew became the acting director of the new Center for Alzheimer’s and Related Dementias. Singleton currently serves on the scientific advisory board of the Lewy Body Dementia Association and is a member of the editorial boards of Neurodegenerative Diseases, Neurobiology of Disease, Neurogenetics, Movement Disorders (Associate Editor), Lancet Neurology, Journal of Parkinson's Disease, NPJ Parkinson's Disease (Associate Editor), and the Journal of Huntington's Disease. His other honors include the 2019 Robert A. Pritzker Award for Leadership in Parkinson’s Research, a 2017 American Academy of Neurology Movement Disorders Award and an Honorary Doctorate from his alma mater, the University of Sunderland.